{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["autoantibody", "gingivitis", "infection", "periodontitis", "rheumatic diseases", "rheumatoid arthritis"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30012973", "DateCompleted": {"Year": "2018", "Month": "11", "Day": "26"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "07", "Day": "16"}], "Language": ["eng"], "ELocationID": ["908", "10.3390/nu10070908"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "10", "Issue": "7", "PubDate": {"Year": "2018", "Month": "Jul", "Day": "16"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "Curcumin for the Management of Periodontitis and Early ACPA-Positive Rheumatoid Arthritis: Killing Two Birds with One Stone.", "Abstract": {"AbstractText": ["We propose curcumin as a preventive measure to avoid/manage periodontitis (PD), and as a natural immunosuppressant for rheumatoid arthritis (RA). PD, mainly caused by <i>Porphyromonas gingivalis</i> forming biofilm and leading to tooth decay, is a major public health issue and a risk factor for the development of RA in humans. <i>P. gingivalis</i> is able to trigger experimental autoimmune arthritis in animal models and in humans can induce citrullinated peptides, which not only are a source of anti-citrullinated antibodies (ACPAs), but also participate in autoreactive responses and disease development. Curcumin appears to have efficient anti-bacterial activity against <i>P. gingivalis</i> infection and biofilm formation. In addition to antibacterial, anti-oxidant, and anti-inflammatory action, curcumin exerts unique immunosuppressant properties via the inhibition of Th17 pro-inflammatory responses and promotion of regulatory T cells, thus suppressing autoimmunity. We introduce curcumin as a natural product for the management of both PD and RA-related autoreactivity, possibly also as a preventive measure in early RA or individuals at high risk to develop RA."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University of Thessaly and University General Hospital of Larissa, 41110 Larissa, Greece. eleniaster91@gmail.com."}], "LastName": "Asteriou", "ForeName": "Eleni", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University of Thessaly and University General Hospital of Larissa, 41110 Larissa, Greece. gkoutzou@med.uth.gr."}], "LastName": "Gkoutzourelas", "ForeName": "Athanasios", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University of Thessaly and University General Hospital of Larissa, 41110 Larissa, Greece. mavropoulos_thanos@hotmail.com."}], "LastName": "Mavropoulos", "ForeName": "Athanasios", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University of Thessaly and University General Hospital of Larissa, 41110 Larissa, Greece. cgk2005@gmail.com."}], "LastName": "Katsiari", "ForeName": "Christina", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University of Thessaly and University General Hospital of Larissa, 41110 Larissa, Greece. lsakkas@med.uth.gr."}], "LastName": "Sakkas", "ForeName": "Lazaros I", "Initials": "LI"}, {"Identifier": ["0000-0002-9697-7902"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University of Thessaly and University General Hospital of Larissa, 41110 Larissa, Greece. bogdanos@med.uth.gr."}], "LastName": "Bogdanos", "ForeName": "Dimitrios P", "Initials": "DP"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Citrullinated Protein Antibodies"}, {"RegistryNumber": "0", "NameOfSubstance": "Antirheumatic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunosuppressive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "IT942ZTH98", "NameOfSubstance": "Curcumin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification", "therapeutic use"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": ["blood", "immunology"], "DescriptorName": "Anti-Citrullinated Protein Antibodies"}, {"QualifierName": ["isolation & purification", "therapeutic use"], "DescriptorName": "Antirheumatic Agents"}, {"QualifierName": ["blood", "drug therapy", "immunology"], "DescriptorName": "Arthritis, Rheumatoid"}, {"QualifierName": ["chemistry"], "DescriptorName": "Curcumin"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["isolation & purification", "therapeutic use"], "DescriptorName": "Immunosuppressive Agents"}, {"QualifierName": ["drug therapy", "immunology", "microbiology"], "DescriptorName": "Periodontitis"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["isolation & purification", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects", "immunology", "pathogenicity"], "DescriptorName": "Porphyromonas gingivalis"}, {"QualifierName": [], "DescriptorName": "Risk Factors"}, {"QualifierName": ["drug effects", "immunology"], "DescriptorName": "T-Lymphocytes, Regulatory"}, {"QualifierName": ["drug effects", "immunology"], "DescriptorName": "Th17 Cells"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "McInnes I.B., Schett G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 2011;365:2205\u20132219. doi: 10.1056/NEJMra1004965.", "ArticleIdList": ["10.1056/NEJMra1004965", "22150039"]}, {"Citation": "Choy E.H., Panayi G.S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Eng. J. Med. 2001;344:907\u2013916. doi: 10.1056/NEJM200103223441207.", "ArticleIdList": ["10.1056/NEJM200103223441207", "11259725"]}, {"Citation": "Sakkas L.I., Xu B., Artlett C.M., Lu S., Jimenez S.A., Platsoucas C.D. Oligoclonal T cell expansion in the skin of patients with systemic sclerosis. J. Immunol. 2002;168:3649\u20133659. doi: 10.4049/jimmunol.168.7.3649.", "ArticleIdList": ["10.4049/jimmunol.168.7.3649", "11907131"]}, {"Citation": "Barouta G., Katsiari C.G., Alexiou I., Liaskos C., Varna A., Bogdanos D.P., Germenis A.E., Sakkas L.I. Anti-mcv antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis. Clin. Rheumatol. 2017;36:885\u2013894.", "ArticleIdList": ["27943044"]}, {"Citation": "Wordsworth B.P., Lanchbury J.S., Sakkas L.I., Welsh K.I., Panayi G.S., Bell J.I. Hla-dr4 subtype frequencies in rheumatoid arthritis indicate that DRB 1 is the major susceptibility locus within the HLA class ii region. Proc. Natl. Acad. Sci. USA. 1989;86:10049\u201310053. doi: 10.1073/pnas.86.24.10049.", "ArticleIdList": ["10.1073/pnas.86.24.10049", "PMC298641", "2481309"]}, {"Citation": "Gregersen P.K., Silver J., Winchester R.J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987;30:1205\u20131213. doi: 10.1002/art.1780301102.", "ArticleIdList": ["10.1002/art.1780301102", "2446635"]}, {"Citation": "Glant T.T., Mikecz K., Rauch T.A. Epigenetics in the pathogenesis of rheumatoid arthritis. BMC Med. 2014;12:35. doi: 10.1186/1741-7015-12-35.", "ArticleIdList": ["10.1186/1741-7015-12-35", "PMC3936819", "24568138"]}, {"Citation": "Sakkas L.I., Daoussis D., Liossis S.-N., Bogdanos D.P. The infectious basis of ACPA-positive rheumatoid arthritis. Front. Microbiol. 2017;8:1853. doi: 10.3389/fmicb.2017.01853.", "ArticleIdList": ["10.3389/fmicb.2017.01853", "PMC5627006", "29033912"]}, {"Citation": "McInnes I.B., Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. 2017;389:2328\u20132337. doi: 10.1016/S0140-6736(17)31472-1.", "ArticleIdList": ["10.1016/S0140-6736(17)31472-1", "28612747"]}, {"Citation": "Kudaeva F.M., Speechley M.R., Pope J.E. A systematic review of viral exposures as a risk for rheumatoid arthritis. Semin. Arthritis Rheum. 2018 doi: 10.1016/j.semarthrit.2018.03.011.", "ArticleIdList": ["10.1016/j.semarthrit.2018.03.011", "29747994"]}, {"Citation": "Scherer H.U., Huizinga T.W.J., Kronke G., Schett G., Toes R.E.M. The B cell response to citrullinated antigens in the development of rheumatoid arthritis. Nat. Rev. Rheumatol. 2018;14:157\u2013169. doi: 10.1038/nrrheum.2018.10.", "ArticleIdList": ["10.1038/nrrheum.2018.10", "29416134"]}, {"Citation": "Kuijper T.M., Folmer R., Stolk E.A., Hazes J.M.W., Luime J.J. Doctors\u2019 preferences in de-escalating dmards in rheumatoid arthritis: A discrete choice experiment. Arthritis Res. Ther. 2017;19:78. doi: 10.1186/s13075-017-1287-z.", "ArticleIdList": ["10.1186/s13075-017-1287-z", "PMC5405491", "28446212"]}, {"Citation": "Tanaka Y. Rheumatoid arthritis: Dmard de-escalation\u2014Let the patient guide you. Nat. Rev. Rheum. 2017;13:637\u2013638. doi: 10.1038/nrrheum.2017.128.", "ArticleIdList": ["10.1038/nrrheum.2017.128", "28794513"]}, {"Citation": "Van Nies J.A., Krabben A., Schoones J.W., Huizinga T.W., Kloppenburg M., van der Helm-van Mil A.H. What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review. Ann. Rheum. Dis. 2014;73:861\u2013870. doi: 10.1136/annrheumdis-2012-203130.", "ArticleIdList": ["10.1136/annrheumdis-2012-203130", "23572339"]}, {"Citation": "O\u2019Dell J.R. Treating rheumatoid arthritis early: A window of opportunity? Arthritis Rheum. 2002;46:283\u2013285. doi: 10.1002/art.10092.", "ArticleIdList": ["10.1002/art.10092", "11840429"]}, {"Citation": "Rahmani A.H., Alsahli M.A., Aly S.M., Khan M.A., Aldebasi Y.H. Role of curcumin in disease prevention and treatment. Adv. Biomed. Res. 2018;7:38. doi: 10.4103/abr.abr_147_16.", "ArticleIdList": ["10.4103/abr.abr_147_16", "PMC5852989", "29629341"]}, {"Citation": "Aggarwal B.B., Sundaram C., Malani N., Ichikawa H. Curcumin: The Indian solid gold. Adv. Exp. Med. Biol. 2007;595:1\u201375.", "ArticleIdList": ["17569205"]}, {"Citation": "Asher G.N., Spelman K. Clinical utility of curcumin extract. Altern. Ther. Health Med. 2013;19:20\u201322.", "ArticleIdList": ["23594449"]}, {"Citation": "Bright J.J. Curcumin and autoimmune disease. Adv. Exp. Med. Biol. 2007;595:425\u2013451.", "ArticleIdList": ["17569223"]}, {"Citation": "Momtazi-Borojeni A.A., Haftcheshmeh S.M., Esmaeili S.A., Johnston T.P., Abdollahi E., Sahebkar A. Curcumin: A natural modulator of immune cells in systemic lupus erythematosus. Autoimmun. Rev. 2018;17:125\u2013135. doi: 10.1016/j.autrev.2017.11.016.", "ArticleIdList": ["10.1016/j.autrev.2017.11.016", "29180127"]}, {"Citation": "Park M.J., Moon S.J., Lee S.H., Yang E.J., Min J.K., Cho S.G., Yang C.W., Park S.H., Kim H.Y., Cho M.L. Curcumin attenuates acute graft-versus-host disease severity via in vivo regulations on th1, th17 and regulatory t cells. PLoS ONE. 2013;8:e67171. doi: 10.1371/journal.pone.0067171.", "ArticleIdList": ["10.1371/journal.pone.0067171", "PMC3688629", "23840617"]}, {"Citation": "Xie L., Li X.K., Takahara S. Curcumin has bright prospects for the treatment of multiple sclerosis. Int. Immunopharmacol. 2011;11:323\u2013330. doi: 10.1016/j.intimp.2010.08.013.", "ArticleIdList": ["10.1016/j.intimp.2010.08.013", "20828641"]}, {"Citation": "Dou Y., Luo J., Wu X., Wei Z., Tong B., Yu J., Wang T., Zhang X., Yang Y., Yuan X.L., et al. Curcumin attenuates collagen-induced inflammatory response through the \u201cgut-brain axis\u201d. J. Neuroinflamm. 2018;15:6. doi: 10.1186/s12974-017-1047-7.", "ArticleIdList": ["10.1186/s12974-017-1047-7", "PMC5756354", "29306322"]}, {"Citation": "Yang Y., Wu X., Wei Z., Dou Y., Zhao D., Wang T., Bian D., Tong B., Xia Y., Xia Y., et al. Oral curcumin has anti-arthritic efficacy through somatostatin generation via CAMP/PKA and Ca(2+)/CaMKII signaling pathways in the small intestine. Pharmacol. Res. 2015;95\u201396:71\u201381. doi: 10.1016/j.phrs.2015.03.016.", "ArticleIdList": ["10.1016/j.phrs.2015.03.016", "25836921"]}, {"Citation": "Zheng Z., Sun Y., Liu Z., Zhang M., Li C., Cai H. The effect of curcumin and its nanoformulation on adjuvant-induced arthritis in rats. Drug Des. Dev. Ther. 2015;9:4931\u20134942.", "ArticleIdList": ["PMC4555965", "26345159"]}, {"Citation": "Kuncha M., Naidu V.G., Sahu B.D., Gadepalli S.G., Sistla R. Curcumin potentiates the anti-arthritic effect of prednisolone in freund\u2019s complete adjuvant-induced arthritic rats. J. Pharm. Pharmacol. 2014;66:133\u2013144. doi: 10.1111/jphp.12156.", "ArticleIdList": ["10.1111/jphp.12156", "24138213"]}, {"Citation": "Banji D., Pinnapureddy J., Banji O.J., Saidulu A., Hayath M.S. Synergistic activity of curcumin with methotrexate in ameliorating freund\u2019s complete adjuvant induced arthritis with reduced hepatotoxicity in experimental animals. Eur. J. Pharmacol. 2011;668:293\u2013298. doi: 10.1016/j.ejphar.2011.06.006.", "ArticleIdList": ["10.1016/j.ejphar.2011.06.006", "21693118"]}, {"Citation": "Chen L., Liu T., Wang Q., Liu J. Anti-inflammatory effect of combined tetramethylpyrazine, resveratrol and curcumin in vivo. BMC Complement. Altern. Med. 2017;17:233. doi: 10.1186/s12906-017-1739-7.", "ArticleIdList": ["10.1186/s12906-017-1739-7", "PMC5408375", "28449676"]}, {"Citation": "Sumeet G., Rachna K., Samrat C., Ipshita C., Vikas J., Manu S. Anti inflammatory and anti arthritic activity of different milk based formulation of curcumin in rat model. Curr. Drug Deliv. 2018;15:205\u2013214. doi: 10.2174/1567201814666170320142851.", "ArticleIdList": ["10.2174/1567201814666170320142851", "28322165"]}, {"Citation": "Jeengar M.K., Shrivastava S., Mouli Veeravalli S.C., Naidu V.G., Sistla R. Amelioration of FCA induced arthritis on topical application of curcumin in combination with emu oil. Nutrition. 2016;32:955\u2013964. doi: 10.1016/j.nut.2016.02.009.", "ArticleIdList": ["10.1016/j.nut.2016.02.009", "27178879"]}, {"Citation": "Kamarudin T.A., Othman F., Mohd Ramli E.S., Md Isa N., Das S. Protective effect of curcumin on experimentally induced arthritic rats: Detailed histopathological study of the joints and white blood cell count. EXCLI J. 2012;11:226\u2013236.", "ArticleIdList": ["PMC4928023", "27366139"]}, {"Citation": "Chen J.J., Dai L., Zhao L.X., Zhu X., Cao S., Gao Y.J. Intrathecal curcumin attenuates pain hypersensitivity and decreases spinal neuroinflammation in rat model of monoarthritis. Sci. Rep. 2015;5:10278. doi: 10.1038/srep10278.", "ArticleIdList": ["10.1038/srep10278", "PMC4437313", "25988362"]}, {"Citation": "Arora R., Kuhad A., Kaur I.P., Chopra K. Curcumin loaded solid lipid nanoparticles ameliorate adjuvant-induced arthritis in rats. Eur. J. Pain. 2015;19:940\u2013952. doi: 10.1002/ejp.620.", "ArticleIdList": ["10.1002/ejp.620", "25400173"]}, {"Citation": "Funk J.L., Oyarzo J.N., Frye J.B., Chen G., Lantz R.C., Jolad S.D., Solyom A.M., Timmermann B.N. Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. J. Nat. Prod. 2006;69:351\u2013355. doi: 10.1021/np050327j.", "ArticleIdList": ["10.1021/np050327j", "PMC2533857", "16562833"]}, {"Citation": "Okamoto Y., Tanaka M., Fukui T., Masuzawa T. Inhibition of interleukin 17 production by curcumin in mice with collagen-induced arthritis. Biomed. Res. 2011;22:299\u2013304."}, {"Citation": "Moon D.O., Kim M.O., Choi Y.H., Park Y.M., Kim G.Y. Curcumin attenuates inflammatory response in il-1beta-induced human synovial fibroblasts and collagen-induced arthritis in mouse model. Int. Immunopharmacol. 2010;10:605\u2013610. doi: 10.1016/j.intimp.2010.02.011.", "ArticleIdList": ["10.1016/j.intimp.2010.02.011", "20188213"]}, {"Citation": "Huang G., Xu Z., Huang Y., Duan X., Gong W., Zhang Y., Fan J., He F. Curcumin protects against collagen-induced arthritis via suppression of baff production. J. Clin. Immunol. 2013;33:550\u2013557. doi: 10.1007/s10875-012-9839-0.", "ArticleIdList": ["10.1007/s10875-012-9839-0", "23184090"]}, {"Citation": "Mun S.H., Kim H.S., Kim J.W., Ko N.Y., Kim D.K., Lee B.Y., Kim B., Won H.S., Shin H.S., Han J.W., et al. Oral administration of curcumin suppresses production of matrix metalloproteinase (MMP)-1 and MMP-3 to ameliorate collagen-induced arthritis: Inhibition of the PKC\u03b4/JNK/c-jun pathway. J. Pharmacol. Sci. 2009;111:13\u201321. doi: 10.1254/jphs.09134FP.", "ArticleIdList": ["10.1254/jphs.09134FP", "19763044"]}, {"Citation": "Xie L., Li X.K., Funeshima-Fuji N., Kimura H., Matsumoto Y., Isaka Y., Takahara S. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of il-17 production. Int. Immunopharmacol. 2009;9:575\u2013581. doi: 10.1016/j.intimp.2009.01.025.", "ArticleIdList": ["10.1016/j.intimp.2009.01.025", "19539560"]}, {"Citation": "Park M.J., Lee S.H., Kim E.K., Lee E.J., Baek J.A., Park S.H., Kwok S.K., Cho M.L. Interleukin-10 produced by myeloid-derived suppressor cells is critical for the induction of tregs and attenuation of rheumatoid inflammation in mice. Sci. Rep. 2018;8:3753. doi: 10.1038/s41598-018-21856-2.", "ArticleIdList": ["10.1038/s41598-018-21856-2", "PMC5830490", "29491381"]}, {"Citation": "Lee G., Chung H.S., Lee K., Lee H., Kim M., Bae H. Curcumin attenuates the scurfy-induced immune disorder, a model of ipex syndrome, with inhibiting TH1/TH2/TH17 responses in mice. Phytomedicine. 2017;33:1\u20136. doi: 10.1016/j.phymed.2017.01.008.", "ArticleIdList": ["10.1016/j.phymed.2017.01.008", "28887914"]}, {"Citation": "Mollazadeh H., Cicero A.F.G., Blesso C.N., Pirro M., Majeed M., Sahebkar A. Immune modulation by curcumin: The role of interleukin-10. Crit. Rev. Food Sci. Nutr. 2017:1\u201313. doi: 10.1080/10408398.2017.1358139.", "ArticleIdList": ["10.1080/10408398.2017.1358139", "28799796"]}, {"Citation": "Rogers N.M., Kireta S., Coates P.T. Curcumin induces maturation-arrested dendritic cells that expand regulatory t cells in vitro and in vivo. Clin. Exp. Immunol. 2010;162:460\u2013473. doi: 10.1111/j.1365-2249.2010.04232.x.", "ArticleIdList": ["10.1111/j.1365-2249.2010.04232.x", "PMC3026549", "21070208"]}, {"Citation": "Inglis J.J., Notley C.A., Essex D., Wilson A.W., Feldmann M., Anand P., Williams R. Collagen-induced arthritis as a model of hyperalgesia: Functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade. Arthritis Rheum. 2007;56:4015\u20134023. doi: 10.1002/art.23063.", "ArticleIdList": ["10.1002/art.23063", "18050216"]}, {"Citation": "Hashimoto M. Th17 in animal models of rheumatoid arthritis. J. Clin. Med. 2017;6:73. doi: 10.3390/jcm6070073.", "ArticleIdList": ["10.3390/jcm6070073", "PMC5532581", "28753982"]}, {"Citation": "Nakae S., Nambu A., Sudo K., Iwakura Y. Suppression of immune induction of collagen-induced arthritis in il-17-deficient mice. J. Immunol. 2003;171:6173\u20136177. doi: 10.4049/jimmunol.171.11.6173.", "ArticleIdList": ["10.4049/jimmunol.171.11.6173", "14634133"]}, {"Citation": "Cong Y., Wang L., Konrad A., Schoeb T., Elson C.O. Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine-protective regulatory t cells. Eur. J. Immunol. 2009;39:3134\u20133146. doi: 10.1002/eji.200939052.", "ArticleIdList": ["10.1002/eji.200939052", "19839007"]}, {"Citation": "Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., Levy-Lahad E., Mazzella M., Goulet O., Perroni L., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 2001;27:18\u201320. doi: 10.1038/83707.", "ArticleIdList": ["10.1038/83707", "11137992"]}, {"Citation": "Bakir B., Yetkin Ay Z., Buyukbayram H.I., Kumbul Doguc D., Bayram D., Candan I.A., Uskun E. Effect of curcumin on systemic T helper 17 cell response; gingival expressions of interleukin-17 and retinoic acid receptor-related orphan receptor gammat; and alveolar bone loss in experimental periodontitis. J. Periodontol. 2016;87:e183\u2013e191. doi: 10.1902/jop.2016.150722.", "ArticleIdList": ["10.1902/jop.2016.150722", "27452394"]}, {"Citation": "Hofstetter H.H., Toyka K.V., Tary-Lehmann M., Lehmann P.V. Kinetics and organ distribution of il-17-producing cd4 cells in proteolipid protein 139-151 peptide-induced experimental autoimmune encephalomyelitis of SJL mice. J. Immunol. 2007;178:1372\u20131378. doi: 10.4049/jimmunol.178.3.1372.", "ArticleIdList": ["10.4049/jimmunol.178.3.1372", "17237384"]}, {"Citation": "Bruck J., Holstein J., Glocova I., Seidel U., Geisel J., Kanno T., Kumagai J., Mato N., Sudowe S., Widmaier K., et al. Nutritional control of IL-23/TH17-mediated autoimmune disease through ho-1/stat3 activation. Sci. Rep. 2017;7:44482. doi: 10.1038/srep44482.", "ArticleIdList": ["10.1038/srep44482", "PMC5349589", "28290522"]}, {"Citation": "Chandran B., Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother. Res. PTR. 2012;26:1719\u20131725. doi: 10.1002/ptr.4639.", "ArticleIdList": ["10.1002/ptr.4639", "22407780"]}, {"Citation": "Amalraj A., Varma K., Jacob J., Divya C., Kunnumakkara A.B., Stohs S.J., Gopi S. A novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: A randomized, double-blind, placebo-controlled, two-dose, three-arm, and parallel-group study. J. Med. Food. 2017;20:1022\u20131030. doi: 10.1089/jmf.2017.3930.", "ArticleIdList": ["10.1089/jmf.2017.3930", "28850308"]}, {"Citation": "Zorofchian Moghadamtousi S., Abdul Kadir H., Hassandarvish P., Tajik H., Abubakar S., Zandi K. A review on antibacterial, antiviral, and antifungal activity of curcumin. BioMed Res. Int. 2014;2014:186864. doi: 10.1155/2014/186864.", "ArticleIdList": ["10.1155/2014/186864", "PMC4022204", "24877064"]}, {"Citation": "Rai D., Singh J.K., Roy N., Panda D. Curcumin inhibits FTsZ assembly: An attractive mechanism for its antibacterial activity. Biochem. J. 2008;410:147\u2013155. doi: 10.1042/BJ20070891.", "ArticleIdList": ["10.1042/BJ20070891", "17953519"]}, {"Citation": "Sarkar A., De R., Mukhopadhyay A.K. Curcumin as a potential therapeutic candidate for helicobacter pylori associated diseases. World J. Gastroenterol. 2016;22:2736\u20132748. doi: 10.3748/wjg.v22.i9.2736.", "ArticleIdList": ["10.3748/wjg.v22.i9.2736", "PMC4777996", "26973412"]}, {"Citation": "De R., Kundu P., Swarnakar S., Ramamurthy T., Chowdhury A., Nair G.B., Mukhopadhyay A.K. Antimicrobial activity of curcumin against helicobacter pylori isolates from India and during infections in mice. Antimicrob. Agents Chemother. 2009;53:1592\u20131597. doi: 10.1128/AAC.01242-08.", "ArticleIdList": ["10.1128/AAC.01242-08", "PMC2663130", "19204190"]}, {"Citation": "Zandi K., Ramedani E., Mohammadi K., Tajbakhsh S., Deilami I., Rastian Z., Fouladvand M., Yousefi F., Farshadpour F. Evaluation of antiviral activities of curcumin derivatives against HSV-1 in vero cell line. Nat. Prod. Commun. 2010;5:1935\u20131938.", "ArticleIdList": ["21299124"]}, {"Citation": "Ferreira V.H., Nazli A., Dizzell S.E., Mueller K., Kaushic C. The anti-inflammatory activity of curcumin protects the genital mucosal epithelial barrier from disruption and blocks replication of HIV-1 and HSV-2. PLoS ONE. 2015;10:e0124903. doi: 10.1371/journal.pone.0124903.", "ArticleIdList": ["10.1371/journal.pone.0124903", "PMC4391950", "25856395"]}, {"Citation": "Kutluay S.B., Doroghazi J., Roemer M.E., Triezenberg S.J. Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity. Virology. 2008;373:239\u2013247. doi: 10.1016/j.virol.2007.11.028.", "ArticleIdList": ["10.1016/j.virol.2007.11.028", "PMC2668156", "18191976"]}, {"Citation": "Kumar A., Dhamgaye S., Maurya I.K., Singh A., Sharma M., Prasad R. Curcumin targets cell wall integrity via calcineurin-mediated signaling in Candida albicans. Antimicrob. Agents Chem. 2014;58:167\u2013175. doi: 10.1128/AAC.01385-13.", "ArticleIdList": ["10.1128/AAC.01385-13", "PMC3910804", "24145527"]}, {"Citation": "Goel A., Kunnumakkara A.B., Aggarwal B.B. Curcumin as \u201ccurecumin\u201d: From kitchen to clinic. Biochem. Pharmacol. 2008;75:787\u2013809. doi: 10.1016/j.bcp.2007.08.016.", "ArticleIdList": ["10.1016/j.bcp.2007.08.016", "17900536"]}, {"Citation": "Bogdanos D.P., Sakkas L.I. From microbiome to infectome in autoimmunity. Curr. Opin. Rheumatol. 2017;29:369\u2013373. doi: 10.1097/BOR.0000000000000394.", "ArticleIdList": ["10.1097/BOR.0000000000000394", "28394824"]}, {"Citation": "Willemze A., Trouw L.A., Toes R.E., Huizinga T.W. The influence of ACPA status and characteristics on the course of RA. Nat. Res. Rheumatol. 2012;8:144\u2013152. doi: 10.1038/nrrheum.2011.204.", "ArticleIdList": ["10.1038/nrrheum.2011.204", "22293763"]}, {"Citation": "Sakkas L.I., Bogdanos D.P., Katsiari C., Platsoucas C.D. Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment. Autoimmun. Res. 2014;13:1114\u20131120. doi: 10.1016/j.autrev.2014.08.012.", "ArticleIdList": ["10.1016/j.autrev.2014.08.012", "25182207"]}, {"Citation": "Van Venrooij W.J., van Beers J.J., Pruijn G.J. Anti-CCP antibodies: The past, the present and the future. Nat. Res. Rheumatol. 2011;7:391\u2013398. doi: 10.1038/nrrheum.2011.76.", "ArticleIdList": ["10.1038/nrrheum.2011.76", "21647203"]}, {"Citation": "Jilani A.A., Mackworth-Young C.G. The role of citrullinated protein antibodies in predicting erosive disease in rheumatoid arthritis: A systematic literature review and meta-analysis. Int. J. Rheumatol. 2015;2015:728610. doi: 10.1155/2015/728610.", "ArticleIdList": ["10.1155/2015/728610", "PMC4364370", "25821469"]}, {"Citation": "Syversen S.W., Gaarder P.I., Goll G.L., Odegard S., Haavardsholm E.A., Mowinckel P., van der Heijde D., Landewe R., Kvien T.K. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: Results from a 10-year longitudinal study. Ann. Rheum. Dis. 2008;67:212\u2013217. doi: 10.1136/ard.2006.068247.", "ArticleIdList": ["10.1136/ard.2006.068247", "17526555"]}, {"Citation": "Nielen M.M., van Schaardenburg D., Reesink H.W., van de Stadt R.J., van der Horst-Bruinsma I.E., de Koning M.H., Habibuw M.R., Vandenbroucke J.P., Dijkmans B.A. Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis Rheum. 2004;50:380\u2013386. doi: 10.1002/art.20018.", "ArticleIdList": ["10.1002/art.20018", "14872479"]}, {"Citation": "Van der Woude D., Rantapaa-Dahlqvist S., Ioan-Facsinay A., Onnekink C., Schwarte C.M., Verpoort K.N., Drijfhout J.W., Huizinga T.W., Toes R.E., Pruijn G.J. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann. Rheum. Dis. 2010;69:1554\u20131561. doi: 10.1136/ard.2009.124537.", "ArticleIdList": ["10.1136/ard.2009.124537", "20448290"]}, {"Citation": "Brink M., Hansson M., Mathsson L., Jakobsson P.J., Holmdahl R., Hallmans G., Stenlund H., Ronnelid J., Klareskog L., Rantapaa-Dahlqvist S. Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis. Arthritis Rheum. 2013;65:899\u2013910. doi: 10.1002/art.37835.", "ArticleIdList": ["10.1002/art.37835", "23310951"]}, {"Citation": "Koga T., Okada A., Fukuda T., Hidaka T., Ishii T., Ueki Y., Kodera T., Nakashima M., Takahashi Y., Honda S., et al. Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in japan. PLoS ONE. 2017;12:e0175281. doi: 10.1371/journal.pone.0175281.", "ArticleIdList": ["10.1371/journal.pone.0175281", "PMC5432072", "28505163"]}, {"Citation": "Alivernini S., Galeazzi M., Peleg H., Tolusso B., Gremese E., Ferraccioli G., Naparstek Y. Is ACPA positivity the main driver for rheumatoid arthritis treatment? Pros and cons. Autoimmun. Rev. 2017;16:1096\u20131102. doi: 10.1016/j.autrev.2017.09.002.", "ArticleIdList": ["10.1016/j.autrev.2017.09.002", "28899798"]}, {"Citation": "McHugh J. Rheumatoid arthritis: IFN\u03b3 drives synovial tissue remodelling. Nat. Rev. Rheumatol. 2018;14:63. doi: 10.1038/nrrheum.2017.221.", "ArticleIdList": ["10.1038/nrrheum.2017.221", "29323347"]}, {"Citation": "Sokolove J., Bromberg R., Deane K.D., Lahey L.J., Derber L.A., Chandra P.E., Edison J.D., Gilliland W.R., Tibshirani R.J., Norris J.M., et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS ONE. 2012;7:e35296. doi: 10.1371/annotation/2e462817-ab93-4d78-95a4-1d8b9d172971.", "ArticleIdList": ["10.1371/annotation/2e462817-ab93-4d78-95a4-1d8b9d172971", "PMC3360701", "22662108"]}, {"Citation": "England B.R., Thiele G.M., Mikuls T.R. Anticitrullinated protein antibodies: Origin and role in the pathogenesis of rheumatoid arthritis. Curr. Opin. Rheumatol. 2017;29:57\u201364. doi: 10.1097/BOR.0000000000000356.", "ArticleIdList": ["10.1097/BOR.0000000000000356", "27755123"]}, {"Citation": "Foulquier C., Sebbag M., Clavel C., Chapuy-Regaud S., Al Badine R., Mechin M.C., Vincent C., Nachat R., Yamada M., Takahara H., et al. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum. 2007;56:3541\u20133553. doi: 10.1002/art.22983.", "ArticleIdList": ["10.1002/art.22983", "17968929"]}, {"Citation": "Anzilotti C., Pratesi F., Tommasi C., Migliorini P. Peptidylarginine deiminase 4 and citrullination in health and disease. Autoimmun. Rev. 2010;9:158\u2013160. doi: 10.1016/j.autrev.2009.06.002.", "ArticleIdList": ["10.1016/j.autrev.2009.06.002", "19540364"]}, {"Citation": "Kidd B.A., Ho P.P., Sharpe O., Zhao X., Tomooka B.H., Kanter J.L., Steinman L., Robinson W.H. Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Arthritis Res. Ther. 2008;10:R119. doi: 10.1186/ar2523.", "ArticleIdList": ["10.1186/ar2523", "PMC2592807", "18826638"]}, {"Citation": "Konig M.F., Paracha A.S., Moni M., Bingham C.O., 3rd, Andrade F. Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology. Ann. Rheum. Dis. 2015;74:2054\u20132061. doi: 10.1136/annrheumdis-2014-205385.", "ArticleIdList": ["10.1136/annrheumdis-2014-205385", "PMC4368502", "24864075"]}, {"Citation": "Hill J.A., Southwood S., Sette A., Jevnikar A.M., Bell D.A., Cairns E. Cutting edge: The conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J. Immunol. 2003;171:538\u2013541. doi: 10.4049/jimmunol.171.2.538.", "ArticleIdList": ["10.4049/jimmunol.171.2.538", "12847215"]}, {"Citation": "Scally S.W., Petersen J., Law S.C., Dudek N.L., Nel H.J., Loh K.L., Wijeyewickrema L.C., Eckle S.B., van Heemst J., Pike R.N., et al. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis. J. Exp. Med. 2013;210:2569\u20132582. doi: 10.1084/jem.20131241.", "ArticleIdList": ["10.1084/jem.20131241", "PMC3832918", "24190431"]}, {"Citation": "Arnoux F., Mariot C., Peen E., Lambert N.C., Balandraud N., Roudier J., Auger I. Peptidyl arginine deiminase immunization induces anticitrullinated protein antibodies in mice with particular MHC types. Proc. Natl. Acad. Sci. USA. 2017;114:E10169\u2013E10177. doi: 10.1073/pnas.1713112114.", "ArticleIdList": ["10.1073/pnas.1713112114", "PMC5703315", "29109281"]}, {"Citation": "Leech T., Bartold P.M. The association between rheumatoid arthritis and periodontitis. Best Pract. Res. Clin. Rheumatol. 2015;29:189\u2013201. doi: 10.1016/j.berh.2015.03.001.", "ArticleIdList": ["10.1016/j.berh.2015.03.001", "26362738"]}, {"Citation": "Yusof Z., Porter S.R., Greenman J., Scully C. Levels of serum igg against Porphyromonas gingivalis in patients with rapidly progressive periodontitis, rheumatoid arthritis and adult periodontitis. J. Nihon Univ. Sch. Dent. 1995;37:197\u2013200. doi: 10.2334/josnusd1959.37.197.", "ArticleIdList": ["10.2334/josnusd1959.37.197", "8820338"]}, {"Citation": "Koziel J., Mydel P., Potempa J. The link between periodontal disease and rheumatoid arthritis: An updated review. Curr. Rheumatol. Rep. 2014;16:408. doi: 10.1007/s11926-014-0408-9.", "ArticleIdList": ["10.1007/s11926-014-0408-9", "PMC3930831", "24458478"]}, {"Citation": "Wegner N., Lundberg K., Kinloch A., Fisher B., Malmstrom V., Feldmann M., Venables P.J. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol. Rev. 2010;233:34\u201354. doi: 10.1111/j.0105-2896.2009.00850.x.", "ArticleIdList": ["10.1111/j.0105-2896.2009.00850.x", "20192991"]}, {"Citation": "Janssen K.M., Vissink A., de Smit M.J., Westra J., Brouwer E. Lessons to be learned from periodontitis. Curr. Opin. Rheumatol. 2013;25:241\u2013247. doi: 10.1097/BOR.0b013e32835d833d.", "ArticleIdList": ["10.1097/BOR.0b013e32835d833d", "23370377"]}, {"Citation": "Hashimoto M., Yamazaki T., Hamaguchi M., Morimoto T., Yamori M., Asai K., Isobe Y., Furu M., Ito H., Fujii T., et al. Periodontitis and Porphyromonas gingivalis in preclinical stage of arthritis patients. PLoS ONE. 2015;10:e0122121. doi: 10.1371/journal.pone.0122121.", "ArticleIdList": ["10.1371/journal.pone.0122121", "PMC4388350", "25849461"]}, {"Citation": "Johansson L., Sherina N., Kharlamova N., Potempa B., Larsson B., Israelsson L., Potempa J., Rantapaa-Dahlqvist S., Lundberg K. Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis. Arthritis Res. Ther. 2016;18:201. doi: 10.1186/s13075-016-1100-4.", "ArticleIdList": ["10.1186/s13075-016-1100-4", "PMC5015325", "27605245"]}, {"Citation": "Lange L., Thiele G.M., McCracken C., Wang G., Ponder L.A., Angeles-Han S.T., Rouster-Stevens K.A., Hersh A.O., Vogler L.B., Bohnsack J.F., et al. Symptoms of periodontitis and antibody responses to Porphyromonas gingivalis in juvenile idiopathic arthritis. Pediatr. Rheumatol. Online J. 2016;14:8. doi: 10.1186/s12969-016-0068-6.", "ArticleIdList": ["10.1186/s12969-016-0068-6", "PMC4748489", "26861944"]}, {"Citation": "Kharlamova N., Jiang X., Sherina N., Potempa B., Israelsson L., Quirke A.M., Eriksson K., Yucel-Lindberg T., Venables P.J., Potempa J., et al. Antibodies to Porphyromonas gingivalis indicate interaction between oral infection, smoking, and risk genes in rheumatoid arthritis etiology. Arthritis Rheumatol. 2016;68:604\u2013613. doi: 10.1002/art.39491.", "ArticleIdList": ["10.1002/art.39491", "PMC4767537", "26554752"]}, {"Citation": "Lundberg K., Kinloch A., Fisher B.A., Wegner N., Wait R., Charles P., Mikuls T.R., Venables P.J. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum. 2008;58:3009\u20133019. doi: 10.1002/art.23936.", "ArticleIdList": ["10.1002/art.23936", "18821669"]}, {"Citation": "Maresz K.J., Hellvard A., Sroka A., Adamowicz K., Bielecka E., Koziel J., Gawron K., Mizgalska D., Marcinska K.A., Benedyk M., et al. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD) PLoS Pathog. 2013;9:e1003627. doi: 10.1371/journal.ppat.1003627.", "ArticleIdList": ["10.1371/journal.ppat.1003627", "PMC3771902", "24068934"]}, {"Citation": "Sandal I., Karydis A., Luo J., Prislovsky A., Whittington K.B., Rosloniec E.F., Dong C., Novack D.V., Mydel P., Zheng S.G., et al. Bone loss and aggravated autoimmune arthritis in HLA-DR\u03b21-bearing humanized mice following oral challenge with Porphyromonas gingivalis. Arthritis Res. Ther. 2016;18:249. doi: 10.1186/s13075-016-1143-6.", "ArticleIdList": ["10.1186/s13075-016-1143-6", "PMC5081677", "27784339"]}, {"Citation": "Nakajima M., Arimatsu K., Kato T., Matsuda Y., Minagawa T., Takahashi N., Ohno H., Yamazaki K. Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of enterobacteria to the liver. PLoS ONE. 2015;10:e0134234. doi: 10.1371/journal.pone.0134234.", "ArticleIdList": ["10.1371/journal.pone.0134234", "PMC4517782", "26218067"]}, {"Citation": "Sato K., Takahashi N., Kato T., Matsuda Y., Yokoji M., Yamada M., Nakajima T., Kondo N., Endo N., Yamamoto R., et al. Aggravation of collagen-induced arthritis by orally administered Porphyromonas gingivalis through modulation of the gut microbiota and gut immune system. Sci. Rep. 2017;7:6955. doi: 10.1038/s41598-017-07196-7.", "ArticleIdList": ["10.1038/s41598-017-07196-7", "PMC5537233", "28761156"]}, {"Citation": "Konig M.F., Abusleme L., Reinholdt J., Palmer R.J., Teles R.P., Sampson K., Rosen A., Nigrovic P.A., Sokolove J., Giles J.T., et al. Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci. Transl. Med. 2016;8:369ra176. doi: 10.1126/scitranslmed.aaj1921.", "ArticleIdList": ["10.1126/scitranslmed.aaj1921", "PMC5384717", "27974664"]}, {"Citation": "Pratesi F., Tommasi C., Anzilotti C., Puxeddu I., Sardano E., Di Colo G., Migliorini P. Antibodies to a new viral citrullinated peptide, VCP2: Fine specificity and correlation with anti-cyclic citrullinated peptide (CCP) and anti-VCP1 antibodies. Clin. Exp. Immunol. 2011;164:337\u2013345. doi: 10.1111/j.1365-2249.2011.04378.x.", "ArticleIdList": ["10.1111/j.1365-2249.2011.04378.x", "PMC3087929", "21413944"]}, {"Citation": "Zhu C., Li F., Wong M.C., Feng X.P., Lu H.X., Xu W. Association between herpesviruses and chronic periodontitis: A meta-analysis based on case-control studies. PLoS ONE. 2015;10:e0144319. doi: 10.1371/journal.pone.0144319.", "ArticleIdList": ["10.1371/journal.pone.0144319", "PMC4677929", "26666412"]}, {"Citation": "Scher J.U., Ubeda C., Equinda M., Khanin R., Buischi Y., Viale A., Lipuma L., Attur M., Pillinger M.H., Weissmann G., et al. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum. 2012;64:3083\u20133094. doi: 10.1002/art.34539.", "ArticleIdList": ["10.1002/art.34539", "PMC3428472", "22576262"]}, {"Citation": "Zhang X., Zhang D., Jia H., Feng Q., Wang D., Liang D., Wu X., Li J., Tang L., Li Y., et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat. Med. 2015;21:895\u2013905. doi: 10.1038/nm.3914.", "ArticleIdList": ["10.1038/nm.3914", "26214836"]}, {"Citation": "Arimatsu K., Yamada H., Miyazawa H., Minagawa T., Nakajima M., Ryder M.I., Gotoh K., Motooka D., Nakamura S., Iida T., et al. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. Sci. Rep. 2014;4:4828. doi: 10.1038/srep04828.", "ArticleIdList": ["10.1038/srep04828", "PMC4010932", "24797416"]}, {"Citation": "Totaro M.C., Cattani P., Ria F., Tolusso B., Gremese E., Fedele A.L., D\u2019Onghia S., Marchetti S., Di Sante G., Canestri S., et al. Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: Analysis of various compartments including the synovial tissue. Arthritis Res. Ther. 2013;15:R66. doi: 10.1186/ar4243.", "ArticleIdList": ["10.1186/ar4243", "PMC4060366", "23777892"]}, {"Citation": "Nonnenmacher C., Dalpke A., Zimmermann S., Flores-De-Jacoby L., Mutters R., Heeg K. DNA from periodontopathogenic bacteria is immunostimulatory for mouse and human immune cells. Infect. Immun. 2003;71:850\u2013856. doi: 10.1128/IAI.71.2.850-856.2003.", "ArticleIdList": ["10.1128/IAI.71.2.850-856.2003", "PMC145359", "12540566"]}, {"Citation": "Klareskog L., Stolt P., Lundberg K., Kallberg H., Bengtsson C., Grunewald J., Ronnelid J., Harris H.E., Ulfgren A.K., Rantapaa-Dahlqvist S., et al. A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54:38\u201346. doi: 10.1002/art.21575.", "ArticleIdList": ["10.1002/art.21575", "16385494"]}, {"Citation": "Mikuls T.R., Payne J.B., Yu F., Thiele G.M., Reynolds R.J., Cannon G.W., Markt J., McGowan D., Kerr G.S., Redman R.S., et al. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol. 2014;66:1090\u20131100. doi: 10.1002/art.38348.", "ArticleIdList": ["10.1002/art.38348", "PMC4115329", "24782175"]}, {"Citation": "Fuggle N.R., Smith T.O., Kaul A., Sofat N. Hand to mouth: A systematic review and meta-analysis of the association between rheumatoid arthritis and periodontitis. Front. Immunol. 2016;7:80. doi: 10.3389/fimmu.2016.00080.", "ArticleIdList": ["10.3389/fimmu.2016.00080", "PMC4774606", "26973655"]}, {"Citation": "Hensvold A.H., Magnusson P.K., Joshua V., Hansson M., Israelsson L., Ferreira R., Jakobsson P.J., Holmdahl R., Hammarstrom L., Malmstrom V., et al. Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: An epidemiological investigation in twins. Ann. Rheum. Dis. 2015;74:375\u2013380. doi: 10.1136/annrheumdis-2013-203947.", "ArticleIdList": ["10.1136/annrheumdis-2013-203947", "24276366"]}, {"Citation": "Petersen P.E., Ogawa H. Strengthening the prevention of periodontal disease: The WHO approach. J. Periodontol. 2005;76:2187\u20132193. doi: 10.1902/jop.2005.76.12.2187.", "ArticleIdList": ["10.1902/jop.2005.76.12.2187", "16332229"]}, {"Citation": "Teles R., Teles F., Frias-Lopez J., Paster B., Haffajee A. Lessons learned and unlearned in periodontal microbiology. Periodontology 2000. 2013;62:95\u2013162. doi: 10.1111/prd.12010.", "ArticleIdList": ["10.1111/prd.12010", "PMC3912758", "23574465"]}, {"Citation": "Ardila C.M., Granada M.I., Guzman I.C. Antibiotic resistance of subgingival species in chronic periodontitis patients. J. Periodontal Res. 2010;45:557\u2013563. doi: 10.1111/j.1600-0765.2010.01274.x.", "ArticleIdList": ["10.1111/j.1600-0765.2010.01274.x", "20546113"]}, {"Citation": "Petti S., Scully C. Polyphenols, oral health and disease: A review. J. Dent. 2009;37:413\u2013423. doi: 10.1016/j.jdent.2009.02.003.", "ArticleIdList": ["10.1016/j.jdent.2009.02.003", "19303186"]}, {"Citation": "Hensvold A.H., Frisell T., Magnusson P.K., Holmdahl R., Askling J., Catrina A.I. How well do ACPA discriminate and predict RA in the general population: A study based on 12 590 population-representative swedish twins. Ann. Rheum. Dis. 2017;76:119\u2013125. doi: 10.1136/annrheumdis-2015-208980.", "ArticleIdList": ["10.1136/annrheumdis-2015-208980", "27125521"]}, {"Citation": "Lappin D.F., Apatzidou D., Quirke A.M., Oliver-Bell J., Butcher J.P., Kinane D.F., Riggio M.P., Venables P., McInnes I.B., Culshaw S. Influence of periodontal disease, Porphyromonas gingivalis and cigarette smoking on systemic anti-citrullinated peptide antibody titres. J. Clin. Periodontol. 2013;40:907\u2013915. doi: 10.1111/jcpe.12138.", "ArticleIdList": ["10.1111/jcpe.12138", "23902301"]}, {"Citation": "Marchesan J.T., Gerow E.A., Schaff R., Taut A.D., Shin S.Y., Sugai J., Brand D., Burberry A., Jorns J., Lundy S.K., et al. Porphyromonas gingivalis oral infection exacerbates the development and severity of collagen-induced arthritis. Arthritis Res. Ther. 2013;15:R186. doi: 10.1186/ar4376.", "ArticleIdList": ["10.1186/ar4376", "PMC3979094", "24456966"]}, {"Citation": "Chen D., Nie M., Fan M.W., Bian Z. Anti-inflammatory activity of curcumin in macrophages stimulated by lipopolysaccharides from Porphyromonas gingivalis. Pharmacology. 2008;82:264\u2013269. doi: 10.1159/000161127.", "ArticleIdList": ["10.1159/000161127", "18849645"]}, {"Citation": "Zhou T., Chen D., Li Q., Sun X., Song Y., Wang C. Curcumin inhibits inflammatory response and bone loss during experimental periodontitis in rats. Acta Odontol. Scand. 2013;71:349\u2013356. doi: 10.3109/00016357.2012.682092.", "ArticleIdList": ["10.3109/00016357.2012.682092", "22554269"]}, {"Citation": "Hu P., Huang P., Chen M.W. Curcumin attenuates cyclooxygenase-2 expression via inhibition of the nf-kappab pathway in lipopolysaccharide-stimulated human gingival fibroblasts. Cell Biol. Int. 2013;37:443\u2013448. doi: 10.1002/cbin.10050.", "ArticleIdList": ["10.1002/cbin.10050", "23494805"]}, {"Citation": "Gottumukkala S.N., Koneru S., Mannem S., Mandalapu N. Effectiveness of sub gingival irrigation of an indigenous 1% curcumin solution on clinical and microbiological parameters in chronic periodontitis patients: A pilot randomized clinical trial. Cont. Clin. Dent. 2013;4:186\u2013191. doi: 10.4103/0976-237X.114874.", "ArticleIdList": ["10.4103/0976-237X.114874", "PMC3757880", "24015007"]}, {"Citation": "Gu Y., Lee H.M., Napolitano N., Clemens M., Zhang Y., Sorsa T., Zhang Y., Johnson F., Golub L.M. 4-methoxycarbonyl curcumin: A unique inhibitor of both inflammatory mediators and periodontal inflammation. Med. Inflamm. 2013;2013:329740. doi: 10.1155/2013/329740.", "ArticleIdList": ["10.1155/2013/329740", "PMC3886587", "24453415"]}, {"Citation": "Anuradha B.R., Bai Y.D., Sailaja S., Sudhakar J., Priyanka M., Deepika V. Evaluation of anti-inflammatory effects of curcumin gel as an adjunct to scaling and root planing: A clinical study. J. Int. Oral Health JIOH. 2015;7:90\u201393.", "ArticleIdList": ["PMC4513784", "26229378"]}, {"Citation": "Nagasri M., Madhulatha M., Musalaiah S.V., Kumar P.A., Krishna C.H., Kumar P.M. Efficacy of curcumin as an adjunct to scaling and root planning in chronic periodontitis patients: A clinical and microbiological study. J. Pharm. Bioallied Sci. 2015;7:S554\u2013S558. doi: 10.4103/0975-7406.163537.", "ArticleIdList": ["10.4103/0975-7406.163537", "PMC4606658", "26538916"]}, {"Citation": "Anitha V., Rajesh P., Shanmugam M., Priya B.M., Prabhu S., Shivakumar V. Comparative evaluation of natural curcumin and synthetic chlorhexidine in the management of chronic periodontitis as a local drug delivery: A clinical and microbiological study. Indian J. Dent. Res. 2015;26:53\u201356. doi: 10.4103/0970-9290.156806.", "ArticleIdList": ["10.4103/0970-9290.156806", "25961616"]}, {"Citation": "Sreedhar A., Sarkar I., Rajan P., Pai J., Malagi S., Kamath V., Barmappa R. Comparative evaluation of the efficacy of curcumin gel with and without photo activation as an adjunct to scaling and root planing in the treatment of chronic periodontitis: A split mouth clinical and microbiological study. J. Nat. Sci. Biol. Med. 2015;6:1021. doi: 10.4103/0976-9668.166100.", "ArticleIdList": ["10.4103/0976-9668.166100", "PMC4630739", "26604595"]}, {"Citation": "Hugar S.S., Patil S., Metgud R., Nanjwade B., Hugar S.M. Influence of application of chlorhexidine gel and curcumin gel as an adjunct to scaling and root planing: A interventional study. J. Nat. Sci. Biol. Med. 2016;7:149\u2013154. doi: 10.4103/0976-9668.184701.", "ArticleIdList": ["10.4103/0976-9668.184701", "PMC4934104", "27433065"]}, {"Citation": "Elavarasu S., Suthanthiran T., Thangavelu A., Alex S., Palanisamy V.K., Kumar T.S. Evaluation of superoxide dismutase levels in local drug delivery system containing 0.2% curcumin strip as an adjunct to scaling and root planing in chronic periodontitis: A clinical and biochemical study. J. Pharm. Bioallied Sci. 2016;8:S48\u2013S52.", "ArticleIdList": ["PMC5074040", "27829747"]}, {"Citation": "Kaur H., Grover V., Malhotra R., Gupta M. Evaluation of curcumin gel as adjunct to scaling & root planing in management of periodontitis-randomized clinical & biochemical investigation. Inf. Disord. Drug Targets. 2018 doi: 10.2174/1871526518666180601073422.", "ArticleIdList": ["10.2174/1871526518666180601073422", "29852877"]}, {"Citation": "Ravishankar P.L., Kumar Y.P., Anila E.N., Chakraborty P., Malakar M., Mahalakshmi R. Effect of local application of curcumin and ornidazole gel in chronic periodontitis patients. Int. J. Pharm. Investig. 2017;7:188\u2013192. doi: 10.4103/jphi.JPHI_82_17.", "ArticleIdList": ["10.4103/jphi.JPHI_82_17", "PMC5903023", "29692978"]}, {"Citation": "Izui S., Sekine S., Maeda K., Kuboniwa M., Takada A., Amano A., Nagata H. Antibacterial activity of curcumin against periodontopathic bacteria. J. Periodontol. 2016;87:83\u201390. doi: 10.1902/jop.2015.150260.", "ArticleIdList": ["10.1902/jop.2015.150260", "26447754"]}, {"Citation": "Bimonte S., Barbieri A., Palma G., Luciano A., Rea D., Arra C. Curcumin inhibits tumor growth and angiogenesis in an orthotopic mouse model of human pancreatic cancer. Biomed. Res. Int. 2013;2013:810423. doi: 10.1155/2013/810423.", "ArticleIdList": ["10.1155/2013/810423", "PMC3842048", "24324975"]}, {"Citation": "Shahzad M., Millhouse E., Culshaw S., Edwards C.A., Ramage G., Combet E. Selected dietary (poly)phenols inhibit periodontal pathogen growth and biofilm formation. Food Funct. 2015;6:719\u2013729. doi: 10.1039/C4FO01087F.", "ArticleIdList": ["10.1039/C4FO01087F", "25585200"]}, {"Citation": "Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: Problems and promises. Mol. Pharm. 2007;4:807\u2013818. doi: 10.1021/mp700113r.", "ArticleIdList": ["10.1021/mp700113r", "17999464"]}, {"Citation": "Naksuriya O., Okonogi S., Schiffelers R.M., Hennink W.E. Curcumin nanoformulations: A review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials. 2014;35:3365\u20133383. doi: 10.1016/j.biomaterials.2013.12.090.", "ArticleIdList": ["10.1016/j.biomaterials.2013.12.090", "24439402"]}, {"Citation": "Joung H.J., Choi M.J., Kim J.T., Park S.H., Park H.J., Shin G.H. Development of food-grade curcumin nanoemulsion and its potential application to food beverage system: Antioxidant property and in vitro digestion. J. Food Sci. 2016;81:N745\u2013N753. doi: 10.1111/1750-3841.13224.", "ArticleIdList": ["10.1111/1750-3841.13224", "26807662"]}]}], "History": [{"Year": "2018", "Month": "6", "Day": "27"}, {"Year": "2018", "Month": "7", "Day": "10"}, {"Year": "2018", "Month": "7", "Day": "12"}, {"Year": "2018", "Month": "7", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "11", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["30012973", "PMC6073415", "10.3390/nu10070908", "nu10070908"]}}]}